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Intr
Improved survival in patients with haematological malig-
nancy (HM) admitted to the intensive care unit (ICU)
has largely been reported in uncontrolled cohorts.
Newly diagnosed patients should be admitted, since
their prognosis is still to be defined. Nevertheless the
admission of the remaining patients remains a matter of
substantial controversy.
Objectives
To analyse the survival of HM patients admitted to ICU
over a 7-year period (from 2008 to 2014).
Methods
We conducted a detailed retrospective study of sequen-
tial adult ICU admissions with HM in a single centre,
considering numerous variables with regard to their
influence on ICU and mortality. Overall survival (OS)
was defined as the time from ICU admission to death
from any cause, and surviving patients were censored at
last follow-up. OS were calculated using the Kaplan-
Meier method estimates and the differences assessed by
the log-rank test. All P-value less than 0.05 were consid-
ered significant.
Results
Overall, 67 HM patients were included, 62% were male,
with a median age of 59 years (IQR: 19-82). The median
APACHE II was 22 (IQR: 12-49). The hematologic
diagnosis was as follow: 25 lymphomas (37%), 9 Multiple
Myelomas (13%), 6 chronic lymphocytic leukaemia
(9%) and 28 acute leukaemia or myeloproliferative or
myelodisplasic syndromes in acute phase (41%). Disease
status at the moment of UCI admission was: 19 (28%)
complete response (CR), 24 (36%) newly diagnosis disease
and 24 (36%) active disease (of those, 18 patients were
refractory to disease specific treatment and 6 patients were
chemosensitive); 67% of patients were on active oncologic
treatment. Principal ICU diagnosis was sepsis (68%).
Median number of organ failure were 2 (IQR: 0-4), and up
to 36% of patients presented neutropenia at the moment
of UCI admission. Median ICU length of stay was 7 days
(IQR: 1-48) and hospital of stay 38 days (IQR: 8-109). ICU
mortality was 46% (25% of patients died the first day of
ICU admission, and 75% died within the first week).
The rates for ICU, 1-month, 6-month and 12 month
mortality were 48%, 55% and 66%, respectively. With a
median follow up of 18.5 months (IQR: 8-66), OS was
31%. Figure 1; Hematologic diagnosis (P = 0.04) Figure 2;
status of the disease at the moment of ICU admission (P =
0.01) Figure 3; and the number of organ failure (≤ 2: 67%
vs ≥ 3: 28%, P = 0.009) were the most powerful predictor
variables associated with an increased mortality.
Conclusions
OS of our HM patients is not worse than that recently
reported from specialist units.The decision for or
against ICU admission of patients with HM should
become dependent of the underlying malignant disease
and especially with the status of the disease at the
moment of admission. Almost 50% of survivors are still
alive one year after ICU admission, suggesting that an
important subgroup of HM patients benefit from ICU
admission.
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Figure 1 Overall Survival.
Figure 2 OS and type of HM in ICU admission.
Figure 3 OS and type of response in ICU admission.
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